for April 2018
⬇️-📆-💊
— Tim Gauthier (@IDstewardship) April 24, 2018
Shortened courses of #antibiotics reviewed here... what patient wouldn’t want less days of therapy? 👌🏼 Let’s do it people!! New pub by @JGPharmD in @PharmacoJournal via @ACCP 📲 https://t.co/MfUp8EeT6f #AbxStewardship #SaveABX relevant to #SHEA2018 and #ECCMID2018 pic.twitter.com/MqAydue6v4
Mortality rates higher in BSI patients treated w/piperacillin-tazobactam compared to those treated w/meropenem (12.3% and 3.7% respectively), MERINO trial https://t.co/vwLqsMM4PO #ECCMID2018 #infectiousdiseases #bacteria #antibiotics #antimicrobials #bloodstreaminfections
— ESCMID (@ESCMID) April 22, 2018
📄🏥👾📊 ...Here is a new article where @julie_justo and I review #antibiogram basics. Hoping this can be a good 🆓 resource for 🙇♂️🙇♀️ students or others learning about #antibioticstewardship 😃
— Tim Gauthier (@IDstewardship) April 5, 2018
📲 https://t.co/txG17zVRKc #ClinMicro #Microbiology #Pharmacy #Medicine pic.twitter.com/JgHWY7jZaN
10,000+ people from 100 countries have enrolled in the #OpenWHO course on antimicrobial stewardship, since it launched in January. The course is free & open to anyone who wants to learn more about using antibiotics wisely. https://t.co/W3ifnLqo8V #AntibioticResistance pic.twitter.com/Wwy1kuTX5q
— WHO/Europe (@WHO_Europe) April 13, 2018
Piperacillin-tazobactam combo should be avoided when treating BSI caused by ceftriaxone-resistant E.coli, K. pneumoniae, MERINO trial found higher mortality rates https://t.co/vwLqsMM4PO #ECCMID2018 #infectiousdiseases #bacteria #antibiotics #antimicrobials #bloodstreaminfections
— ESCMID (@ESCMID) April 22, 2018
A new article by Dr. Pulcini @idpharmd @e_charani @DilipNathwani @SouthAfricanASP
— Antibiotic Steward (@ABsteward) April 4, 2018
Developing core elements and checklist items for global hospital antimicrobial stewardship programmes. #antibioticstewardship https://t.co/JiKaX53tBZ pic.twitter.com/cHRwZ1dcpN
We just published our summary of antimicrobial stewardship and AMR research presented at #ECCMID2018 #ECCMID18 https://t.co/CtoaJRG7vX
— CIDRAP-ASP (@CIDRAP_ASP) April 26, 2018
7-day treatments for Gram-neg bacteraemia (GNB) showed similar results to 14-day treatments, study finds https://t.co/tDjv26zIn7 #ECCMID2018 #infectiousdiseases #GNB #bacteria #antibiotics #antimicrobials
— ESCMID (@ESCMID) April 22, 2018
Recent conceptual and technological advances in monoclonal antibodies (mAbs) development could have an enormous impact on the field of #infectiousdiseases, particularly in the context of emerging infectious disease outbreaks. Learn more: https://t.co/ZPalsEJJLR pic.twitter.com/7EDNPU4qvs
— NEJM (@NEJM) April 28, 2018
New study suggests increased risk of subsequent #sepsis w/in 90 days of discharge for inpatients receiving high-risk ABX (FQ, 3/4 Cephs, BL/BLIs, Clinda, Carbapenems). Risk diminished with receipt of low-risk ABX. More data supporting #Stewardship #ASP https://t.co/1WIxylZFc7 pic.twitter.com/qyR8A3u08c
— Travis Jones (@tmjones6) April 2, 2018
We're developing a Core Stewardship Curriculum for ID fellows with interactive learning modules, videos, real-life scenarios, and communication tips that can influence stewardship skills
— Payal Patel (@Payal_Patel) April 16, 2018
Described here: https://t.co/OBS1TAEXVe
Led by @vera_luther et al
Supported by @IDSAInfo pic.twitter.com/P9YLFuPdOa
Ceftriaxone 1 g and 2 g daily have inadequate activity against MSSA in this integrated pharmacodynamic study https://t.co/lYGPcYq1Cb
— Brad Langford (@BRxAD) April 7, 2018
This new antimicrobial stewardship core curriculum addresses the gaps concerning comprehensive and structured educational resources for training and evaluating ID fellows #CIDstudy https://t.co/fZwZydQreq pic.twitter.com/jzKPMMsgdH
— IDSA (@IDSAInfo) April 17, 2018
New :Adverse events of fluoroquinolones vs. other antimicrobials prescribed in primary care: A systematic review and meta-analysis of randomized controlled trials. https://t.co/3UMC4zQc91 pic.twitter.com/08mbVIDzWq
— Antibiotic Steward (@ABsteward) April 25, 2018
6-day antibiotic treatment of cellulitis resulted in faster and greater rates of relapse in the long term compared w/12-day treatment, study finds https://t.co/ZL0ma2Qx98 #ECCMID2018 #infectiousdiseases #cellulitis #bacteria #antibiotics #antimicrobials #infections
— ESCMID (@ESCMID) April 22, 2018
ASP steers the ship but we need all hands on deck to complete the journey ;A new article by @idpharmd :Antibiotic Stewardship: The Health of the World Depends on It. This article every #pharmacist Needs to read. Great work! #pharmacist https://t.co/T0WNgL22wz pic.twitter.com/QNv9WhTeL0
— Antibiotic Steward (@ABsteward) April 19, 2018
If you are into #abxstewardship, sign up for the @CIDRAP_ASP newsletter. 👍🏼 It’s really well done with diverse and relevant content. 📲 https://t.co/h7ML8b4gIo #Antibiotics pic.twitter.com/LFKWkB2pWy
— Tim Gauthier (@IDstewardship) April 13, 2018
OFID study underscores the importance of correctly classifying patients with a reported penicillin allergy when treating MSSA bacteremia: receiving a beta-lactam antibiotic was the strongest predictor of survival https://t.co/KmTkb1bmVv @PaulSaxMD pic.twitter.com/CjyMeAkSPv
— IDSA (@IDSAInfo) April 3, 2018
A Statewide #AntimicrobialStewardship Collaborative to Improve the Diagnosis and Treatment of Urinary Tract and Skin and Soft Tissue Infections https://t.co/cVu32E1316
— Brad Langford (@BRxAD) April 3, 2018
“When antibiotic resistance develops anywhere, it is a threat to people everywhere.” Antibiotic resistant bacteria do not respect borders: https://t.co/fkQVkaZuvC #AHCJpandemic #saveabx pic.twitter.com/XUXtkvvFZl
— Save Antibiotics (@saveantibiotics) April 14, 2018
Important paper published today in Clin Infect Dis by @IDSAInfo Fellowship Program Directors including @Armstrws @Payal_Patel & @BSchwartzinSF outlining an Antimicrobial Stewardship Curriculum for ID fellows https://t.co/qzY5OwBrQ2
— Carlos del Rio (@CarlosdelRio7) April 17, 2018
Strep throat isn’t just Strep anymore! The most recent organism linked to bacterial pharyngitis is the anaerobic bacterium F. necrophorum. Find out how this and other organisms that cause pharyngitis are diagnosed on a new Bugs & Drugs: https://t.co/BMJhs97KU0 #ASMClinMicro pic.twitter.com/FU6n2HdanY
— ASM (@ASMicrobiology) April 16, 2018
According to new studies published in @mbiojournal, researchers have found that #mice living in residential buildings in #NewYorkCity carry human pathogens with #antibioticresistance genes. https://t.co/znpoUElo3P pic.twitter.com/RBNAk0hFHa
— ASM (@ASMicrobiology) April 17, 2018
Come & visit the BSAC stand (56B) at #ECCMID2018 - @AntibioticLeeds & Tracey Guise have been promoting our FREE eBook on Antimicrobial Stewardship. Anyone can get a copy via https://t.co/h8Kqff3swN pic.twitter.com/8ta8l9W0TV
— Antibiotic Action (@TheUrgentNeed) April 21, 2018
A new systematic review by Dr. Scheetz :No differences in overall risk of clinical failure or mortality between Carbapenems & other β-lactams for treatment of nosocomial pneumonia.
— Antibiotic Steward (@ABsteward) April 15, 2018
The analysis has several limitations though. https://t.co/S6N1zQvG0O pic.twitter.com/cGu66afr4r
Where to find clinical practice guidelines?🤔
— Antibiotic Tweets (@khalideljaaly) April 13, 2018
1- National Guideline Clearinghouse at: https://t.co/MkqR5qB9pA
2- Medline/Pubmed (MeSH: practice guidelines)
3- Medical society & professional organization (e.g., @IDSAInfo @ESCMID @ASHPOfficial guidelines)
4- Clin-eguide
Where else?
📄🤒🏥💉🔬👾
— Tim Gauthier (@IDstewardship) April 26, 2018
New #rapiddiagnostics article focusing on #Verigene with @jpogue1 @emilylheil and @ClaeysKcclaeys 📲 https://t.co/tGWfhNDY51 via @ASMicrobiology
...With NPVs >90% this test is a powerful #abxstewardship tool!!! pic.twitter.com/sHN4e6VJsQ
#eccmid2018 Mark Wilcox: Good looking multi-centre cross-over study of hand drying methods. Jet air dryers associated with significantly more contamination than paper towels (including MRSA and ESBL) https://t.co/TWH3sizADj https://t.co/TR2rIl7r3y
— Jon Otter (@jonotter) April 22, 2018
Antibiotic Stewardship: The Health of the World Depends on It - Debra A. Goff, 2018 https://t.co/9I2BXj4XVS @cidrap_asp @osu_pharmacy @osuwexmed @sidpharm @JGpharmD @sicuPharmd
— Debbie Goff (@idpharmd) April 19, 2018
In an RCT @JAMA_current , fosfomycin💧X1 resulted in a lower clinical success of uUTI vs nitrofurantoin💊 for 5 dayshttps://t.co/vl1LNkrHmR pic.twitter.com/Osa2TDvLke
— Antibiotic Tweets (@khalideljaaly) April 25, 2018
De-escalate #Antibiotic Treament for UTI & #Pneumonia with our 72-hour Antibiotic Time Out Checklist located in our #Antimicrobial Use Toolkit! https://t.co/Fyzdgb0KLb #antimicrobialstewardship #AntimicrobialResistance pic.twitter.com/pEKp8ONqXT
— Michigan HMS (@HMS_MI) April 11, 2018
Sometimes Nothing Is Better Than Something : The Lean Antibiotic Mantra. By @BradSpellberg @mdabxsteward
— Antibiotic Steward (@ABsteward) April 10, 2018
Cc: @SIDPharm @accpinfdprn@IDstewardship @KisgenUF@TAEscmid @BRxADhttps://t.co/dQ6KoLkSq3
Bactericidal vs Bacteriostatic ABs. We were taught wrong all these decades 🙁😗https://t.co/NfkooEKlxO No intrinsic superiority. Dosing and PK/PD and tissue penetration more NB @sportsuzie1974 @NSchellack @AngPharmID @inspired2leadQH @SouthAfricanASP @idpharmd @jasonroberts_pk
— Adrian Brink (@ABpreservation) April 20, 2018
GNB patients on 7-day antibiotic treatment course returned to daily activities faster than patients on 14-day course, study finds https://t.co/tDjv26zIn7 #ECCMID2018 #infectiousdiseases #GNB #bacteria #antibiotics #antimicrobials
— ESCMID (@ESCMID) April 22, 2018
Short courses of antibiotic therapy yield similar clinical outcomes as prolonged courses for Enterobacteriaceae bacteremia, and may protect against subsequent MDRGN bacteria. https://t.co/P0CKwdlyFp
— andrew seaton (@raseaton66) April 5, 2018
In our new policy update, read more about the past year's antimicrobial stewardship initiatives, incl. resources from @BSACandJAC, @saveantibiotics, @CDC_NCEZID, @SHEA_Epi, @SIDPharm, @APIC, @IDSAInfo, @ESCMID, @FINDdx, @Wellcome_AMR, @DRIVE_AB, and more https://t.co/agWhe52Z5c
— CIDRAP-ASP (@CIDRAP_ASP) April 19, 2018
New 💥in cid empirical use of colistin before pathogen identification, with or without a carbapenem, was not associated with survival following severe infections caused by CRGNBs, mainly A. baumannii. #AIDA study group.
— Antibiotic Steward (@ABsteward) April 27, 2018
https://t.co/No0ePA4NHb pic.twitter.com/xOGocFThFs
Have you ever taken an antibiotic to treat a bacterial infection? If so, thank a clinical #microbiologist! We are celebrating #LabWeek, but every week ASM values clinical microbiologists for their hard work. https://t.co/cIcBHK9Tal #MLPW #lab4life #ASMclinmicro pic.twitter.com/PhCXROzk3Q
— ASM (@ASMicrobiology) April 26, 2018
Our preprint "Staphylococcus aureus viewed from the perspective of 40,000+ genomes" is out! Huge effort by @rpetit3 @PeerJPreprints https://t.co/Mui4LGE3Np #Bioinformatics #Genomics #InfectiousDiseases #MRSA
— Timothy Read PhD (@tdread_emory) April 25, 2018
💊📝✅
— Tim Gauthier (@IDstewardship) April 23, 2018
Should an indication be required to accompany all prescriptions? 🤔 How could that be used for #ABXstewardship? New in @AJHPOfficial 📲 https://t.co/Q7vZ4hVNTr via @ASHPOfficial #Pharmacist #Medicine #Antibiotic pic.twitter.com/DVLbAIACQF
Delighted, our study protocol for 'Defining #antimicrobial stewardship competencies for undergraduate health professional education in the UK' finally published! https://t.co/YfDR3iRcts
— Enrique Castro (@castrocloud) April 16, 2018
Study results also out soon(ish)
The number of bacterial species increases with the weight of host organisms, paralleling findings from studies of island biogeography @mbiojournal https://t.co/ptlu1B90uP pic.twitter.com/U8jGPotheh
— ASM (@ASMicrobiology) April 2, 2018
📄 This new article with @IDPharmProf looks interesting. 🔥 Hot topic these days! 📲 https://t.co/i7kZQp9tVB #OutptStewardship #SaveABX pic.twitter.com/FOdud5ZgZr
— Tim Gauthier (@IDstewardship) April 16, 2018
Our octapeptin paper officially out now in Cell Chem Biol, with cover article! A Gram-negative lipopeptide antibiotic active against XDR bacteria, including polymyxin-resistant strains https://t.co/usrV4ocUFc
— Mark Blaskovich (@mark_blaskovich) April 30, 2018
Newly discovered antibiotic class, Odilorhabdins, and how they work.
— Microbes&Infection (@MicrobesInfect) April 7, 2018
The antibiotics are produced by symbiotic bacteria found in soil-dwelling nematode worms, and act on ribosomes of bacteriahttps://t.co/KgG29naRK6 pic.twitter.com/pCd2BzQKMW
AWESOME presentation by @AngelaHuttner at #ECCMID2018 on effect of 5-day nitrofurantoin vs single-dose fosfomycin for uncomplicated UTIs in women. Check out the full publication, hot off the press! https://t.co/BXxn3eG9x0 pic.twitter.com/e3VzwycMG2
— Erin McCreary (@ErinMcCreary) April 22, 2018
Less is more : the uncommon need for vancomycin.
— Antibiotic Steward (@ABsteward) April 19, 2018
In one study :Empiric vancomycin was prescribed for 36% of patients.
MRSA-positive clinical cultures in the cohort was only 1.2%
the risk for clinically defined MRSA infection was 0.8%. #SHEA2018https://t.co/SkS8Iy8IVl
New Resistance Mechanism in the Often Multidrug Resistant Pathogen Acinetobacter baumanni - New research in @ASMicrobiology's #AAC https://t.co/jdkvHlm3dD pic.twitter.com/vcVFuJpP5A
— ASM Newsroom (@ASMnewsroom) April 30, 2018
In a retrospective matched case-control study, co-administration of statins💊 with daptomycin💉 increased the adjusted odds of myopathy & rhabdomyolysis💪😢 . The authors recommended twice weekly CK monitoring & consideration for holding statins.https://t.co/xKXVhpuwC1 pic.twitter.com/ZDclC8Q1Dm
— Antibiotic Tweets (@khalideljaaly) April 19, 2018
https://t.co/ZddUTZYFxb
— Neil Powell (@neilthepcist) April 17, 2018
Come and work in Cornwall as part of a well supported and integrated hospital pharmacy antibiotic stewardship team.
Can colistin resistance be reversed? New ASM Journal articles uncover the molecular mechanism of colistin resistance & describe a natural product that may render colistin once more effective. Read short summaries + find links to the reports on mBiosphere: https://t.co/NKp1N3dHFG pic.twitter.com/0TaedVJ2we
— ASM (@ASMicrobiology) April 15, 2018
Created by Cameron Forbes. Last updated November 10, 2019 at 15:41 EST.